Protalix BioTherapeutics, Inc. Shares Issued, Shares, Share-based Payment Arrangement, Forfeited
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Protalix BioTherapeutics, Inc. shares issued, shares, share-based payment arrangement, forfeited for the quarter ending 2015-09-30 was 0.00 shares.
- Protalix BioTherapeutics, Inc. shares issued, shares, share-based payment arrangement, forfeited for the quarter ending 2015-06-30 was 834.00 shares.
- Protalix BioTherapeutics, Inc. shares issued, shares, share-based payment arrangement, forfeited for the quarter ending 2015-03-31 was 1.67K shares.
- Protalix BioTherapeutics, Inc. shares issued, shares, share-based payment arrangement, forfeited for the quarter ending 2013-09-30 was 0.00 shares.
| Period end | Shares Issued, Shares, Share-based Payment Arrangement, Forfeited 3 month | Shares Issued, Shares, Share-based Payment Arrangement, Forfeited 12 month |
|---|---|---|
| 2015-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | |
| 2015-06-30 | 834.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | |
| 2015-03-31 | 1.67K shares 10-Q · filed 2016-05-09 | |
| 2013-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |